HealthDay News — Depression, anxiety, and suicidal ideation is more common among individuals with atopic dermatitis (AD), according to a study published online in Allergy.
Jacob P. Thyssen, MD, PhD, from the University of Copenhagen in Denmark, and colleagues used survey data from a large general population study to compare prevalences of depression, anxiety, suicidal ideation, and anxiety attacks in adults with and without a history of AD. Additionally, nationwide hospital/clinic registry and prescription data were used to examine the risk of anxiety and depression in Danish adults with mild and moderate-to-severe AD, as well as the risk of hospitalization and suicide.
The researchers found that participants with AD reported clinician-diagnosed depression and anxiety more often than non-AD subjects. Those with AD also had an increased prevalence of suicidal ideation and depressive symptoms. Patients with moderate-to-severe AD had increased risk of antidepressant and anxiolytic medication use, while patients with mild AD only had increased risk of anxiolytic medication use. There was no association between hospitalization or outpatient contacts and depression or anxiety, or risk of suicide in AD patients.
“Depression, anxiety, and suicidal ideation are more common among AD individuals, but do not to lead to psychiatric consultations, hospitalization, or suicide,” the authors write.
Several authors disclosed financial ties to the pharmaceutical industry.
Thyssen JP, Hamann CR, Linneberg A, et al. Atopic dermatitis is associated with anxiety, depression, and suicidal ideation, but not with psychiatric hospitalization or suicide [published online June 20, 2017]. Allergy. doi:10.1111/all.13231